BMS-986278

Generic Name: BMS-986278

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₂₂H_₃₁N_₅O_₅

CAS Number: 2170126-74-4

Unique Ingredient Identifier: 4UN9AOU6G8

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Idiopathic pulmonary fibrosis promising drugs: FOXO3 and beyond

Refoxy Pharma secures $9.58 million to develop IPF drug RP-01 targeting FOXO3. Boehringer Ingelheim plans NDA submission for nerandomilast. Insilico's ISM001-055 and Endeavor's ENV-101 show disease improvement. Vicore's buloxibutid and BMS' BMS-986278 also chart progress. Pliant's bexotegrast mitigates chronic cough in IPF. IPOs and partnerships fuel IPF therapeutic field.

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

Home Terms & Conditions Privacy Policy